ABBV

AbbVie Inc

drug manufacturers - general

Current price

$248.08

+33.14% over 1Y

Ticker pages are provided for informational and educational purposes.

Market cap

$438.31B

Exchange

NYSE

Headquarters

IL, UNITED STATES

About ABBV

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.

Latest news

Sourced via Alpha Vantage

The Globe and Mail · 1d ago

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Eli Lilly & Co (LLY)

Moomoo · 1d ago

BofA Securities Upgrades AbbVie(ABBV.US) to Buy Rating, Raises Target Price to $276

Simply Wall Street · 1d ago

West Pharmaceutical Services (WST) Sells SmartDose Rights, Is The Stock Fully Priced?

Simply Wall Street · 1d ago

West Pharmaceutical Services (WST) Sells SmartDose Rights, Is The Stock Fully Priced?

Investing.com · 1d ago

Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock

Yahoo Finance UK · 1d ago

West Pharmaceutical Services (WST) Sells SmartDose Rights To AbbVie To Refocus Its Business

Yahoo Finance Singapore · 1d ago

West Pharmaceutical Services (WST) Sells SmartDose Rights To AbbVie To Refocus Its Business

GuruFocus · 1d ago

ABBV Maintained by B of A Securities -- Price Target Raised to $276